Innovation

Overview

C3 has been committed to leading the field in tissue engineering technology for skin since novel techniques for the culturing of skin were first developed at the WA Skin Culture Laboratory in 1993.

Product development has continued since the establishment of proprietary culturing techniques that have resulted in the commercial availability of several innovative products that can improve the quality of life for many patients around the world.

The existing product range is supported by a sound development pipeline that will result in the release of new technologies that provide real and needed solutions in the clinical and laboratory arenas.

View more information on:
CellSpray®
ReCell®
Pipeline Products